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Guideline simulationObjectives: Design, implement, and evaluate a new architecture for realistic continuous guideline (GL)-
based decision support, based on a series of requirements that we have identified, such as support for
continuous care, for multiple task types, and for data-driven and user-driven modes.
Methods: We designed and implemented a new continuous GL-based support architecture, PICARD,
which accesses a temporal reasoning engine, and provides several different types of application inter-
faces. We present the new architecture in detail in the current paper. To evaluate the architecture, we
first performed a technical evaluation of the PICARD architecture, using 19 simulated scenarios in the
preeclampsia/toxemia domain. We then performed a functional evaluation with the help of two domain
experts, by generating patient records that simulate 60 decision points from six clinical guideline-based
scenarios, lasting from two days to four weeks. Finally, 36 clinicians made manual decisions in half of the
scenarios, and had access to the automated GL-based support in the other half. The measures used in all
three experiments were correctness and completeness of the decisions relative to the GL.
Results: Mean correctness and completeness in the technical evaluation were 1 ± 0.0 and 0.96 ± 0.03
respectively. The functional evaluation produced only several minor comments from the two experts,
mostly regarding the output’s style; otherwise the system’s recommendations were validated. In the clin-
ically oriented evaluation, the 36 clinicians applied manually approximately 41% of the GL’s recom-
mended actions. Completeness increased to approximately 93% when using PICARD. Manual
correctness was approximately 94.5%, and remained similar when using PICARD; but while 68% of the
manual decisions included correct but redundant actions, only 3% of the actions included in decisions
made when using PICARD were redundant.
Conclusions: The PICARD architecture is technically feasible and is functionally valid, and addresses the
realistic continuous GL-based application requirements that we have defined; in particular, the require-
ment for care over significant time frames. The use of the PICARD architecture in the domain we exam-
ined resulted in enhanced completeness and in reduction of redundancies, and is potentially beneficial
for general GL-based management of chronic patients.
 2015 Elsevier Inc. All rights reserved.1. Introduction
1.1. Requirements for automated application of clinical guidelines
Clinical guidelines (GLs) are a powerful method for standardiza-
tion and uniform improvement of the quality of the medical care
[1]; however, free-text guidelines are often inaccessible at thepoint of care, and in any case, cannot be easily applied accurately
to the patient at hand. Thus, there is a need for automated support
for their specification and application at the point of care. The task
of automated GL application was fairly well investigated in the
recent years [2–5]. According to a study by Isern and Moreno [5],
a computerized GL-based Decision Support System (DSS) infrastruc-
ture requires a central Data Base (DB), a central Medical Knowledge
Base (KB) that stores the knowledge used during the task (some-
times modifying it) and a DSS engine that applies the knowledge
to the data. Fig. 1 shows an abstract view of a typical knowledge-
based DSS architecture provided by this approach: The medical
knowledge of the GLs is stored and retrieved from a central KB
library (examples of knowledge items stored in the KB are the
Fig. 1. An abstract view of the architecture of a knowledge-based medical decision-support system.
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specific drug). The patient data are stored and retrieved from an
Electronic Medical Record (EMR). The DSS engine applies the medi-
cal knowledge to the data to provide alerts and recommendations
at the point of care to care providers (or nurses), to the patient (for
example through messages sent to his mobile), or even to Knowl-
edge Engineers (KEs), to debug or simulate the DSS engine.
However, building on our extensive experience with the DeGeL
architecture [6], the Spock GL-application engine [7], the Uruz
Web-based GL-specification tool [8,9] evaluations, and multiple
prototypical GL applications, such as those described in Section 4,
and on comments of medical domain experts, clinical users, and
the current literature, we further formulated several additional
key requirements for realistic automated GL application at the
point of care, which none of the current frameworks fully support.
The main requirements that we have identified include:
(1) Provision of support for a continuous application of the GLs
over significant stretches of time, providing recommenda-
tions when necessary.
(2) Verifying that the recommendations have actually been car-
ried out within the given time constraints, based on evidence
that exists in the EMR.
(3) Supporting a data-driven, asynchronous application (i.e.,
responding not only to entry of data during a session with
the care provider, or to queries of the care provider, or to
queries of the patient, but also to the arrival of data to the
patient’s record, from other sources and at other times).
(4) Provision of support through different application interfaces
(APIs) for different types of clinical actors (e.g., nurses versus
physicians versus patients), through a scalable, distributed
architecture.Table 1
Comparison of the guideline-based decision-support frameworks; see Section 1.1 for the d
Framework name Req #1 Req #2 Req #3 Req #
EON X
GLIF3 U U
GASTON U U
Proforma U U U
GLARE U U U
NewGuide s U
SAGE U U
PRODIGY X U
Spock X X
Asbru Interpreter X X X
Health Care Services (HeCaSe2) U X(5) Provision of explanations, regarding both the procedural
(workflow-oriented) and declarative (data-interpretation
oriented) aspects of the GL, which are accessible to the users,
an important property for clinical DSSs [10].
1.2. Background: a comparison to common frameworks
Several existing frameworks provide various types of solutions
to the problem of specification and application of clinical GLs;
examples include EON [11,12], GLIF3 [13,14], GASTON [15,16], Pro-
Forma [17,18], GLARE [19,20], NewGuide [21,22], SAGE [23],
PRODIGY [24], Asbru Interpreter [25], SPOCK [7], and Health Care
Services (HeCaSe2) [26,27]. Table 1 categorizes the properties of
several of these leading research frameworks for GL application,
with respect to the requirements introduced in the previous
section.
Note that most of the listed frameworks have only partially
demonstrated full-fledged support for continuous GL application
over time. This includes cases in which the framework’s underlying
language supports, in theory, a specification of continuous GL
application over time, but we have not found any detailed imple-
mentation or demonstration of a complex GL applied over time
using the framework. In addition, most of the frameworks do not
attach to each recommendation an effective explanation that can
justify to the user why a particular DSS recommendation was sug-
gested. Several frameworks do not include, or include only par-
tially, an API that support multiple tasks, such as debugging or
simulation, in addition to GL application. Finally, note that most
frameworks provide only partial support for the verification of
the actual application of an accepted recommendation, e.g., by
enabling the user to explicitly accept the recommendation. But
they do not actually verify that the expected results of applyingescription of each requirement; means partially supported.
4 Req #5 Functional evaluation of the
GL application process
Evaluation of effect on
clinical decision making
X U U
U X
X U X
U U U
X U X
X U
X U X
X U X
X U X
X U X
X U X
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blood-pressure measurement) indeed appear in the EMR.
In addition to lacking some of the desiderata that we have
listed, several reviews [28,29] conclude that there is a lack of
‘‘in-vivo” evaluations in the area of GL application engines, and
suggest the performance of additional evaluations to better under-
stand the effect of GL-based DSS on the decisions’ quality. In partic-
ular, we feel that there is a lack of evaluations that use a simulation
engine that supports the simulation of the application of a GL on a
set of multiple different patient records, over significant periods of
time, including the testing of all of the GL’s relevant scenarios; and
a lack of evaluations of the GL application engine, using real clini-
cians, and a set of either real or realistically generated, in a
GL-driven fashion, longitudinal patient records. In a recent com-
prehensive methodological review summarizing the past decade’s
research regarding the life cycle of computerized GLs [30], Peleg
concluded that additional research should be performed on the
effect of GL-based DSSs on clinicians’ behavior, in particular on
improving their compliance to GLs.
As shown in Table 1, most of the studies presenting the frame-
works that we examined include only technical or functional eval-
uations; however, typically, no full-fledged evaluation was ever
performed over significant time stretches, for the purpose of
assessing whether the use of the framework results in an enhanced
quality of decision making by the clinicians. We assume that this is
the case because it is difficult to make the leap from a technical
(functional) feasibility evaluation to a full quantitative evaluation.
Such an evaluation typically requires the involvement of a large
number of physicians, a detailed experimental design, and signifi-
cant time.
1.3. The objectives of this study
Given our desiderata and the state of the current art of GL appli-
cation frameworks, we have strived in the current study to design
and fully implement a computational framework that supports all
of the aspects of realistic GL application as detailed above, and then
to evaluate it comprehensively with the help of a group of clinical
users, using specific and detailed qualitative and quantitative mea-
sures. The new GL-application architecture, which we refer to as
PICARD,1 is presented in detail in the current paper. At the core of
the new architecture is a new GL-application engine, the PICARD
DSS engine.
1.4. The structure of the current paper
In the next three sections, we present in detail the design of the
PICARD DSS engine (Section 2), its implementation (Section 3), and
two example implementations of the engine (Section 4): A conges-
tive heart failure call center, and a large-scale architecture for
remote care of chronic patients, using sensors on the patients
and the patients’ mobile phones.
We then continue (in Section 5) by describing the technical,
functional, and clinical evaluation of the PICARD DSS engine,
designed so as to answer two main research questions:
(1) Is the design and implementation of an integrated realistic
guideline application framework feasible?1 Jean-Luc Picard was the captain of the USS-Enterprise spaceship in the 1980s TV
series Star Trek: The Next Generation, which was the sequel of the 1960s series Star
Trek. In a metaphorical manner, the GL application framework developed and
evaluated in this thesis is called PICARD because it is the next generation of ‘‘Spock”—
the previous generation GL application tool of our laboratory [7]. The PICARD GL
application engine assists whomever is the captain in charge of therapy—the
physician, the nurse, or even the patient.(2) Does using the GL application framework have a positive
effect on the quality of the physicians’ decisions?
Section 6 presents the results of the three types of evaluation.
We demonstrate that the answer to both of the research questions
is positive, by presenting specific quantitative data regarding each
question.
Section 7 summarizes and discusses the results and their impli-
cation on the efforts to improve the quality of clinicians’ decisions;
Section 8 presents briefly our overall conclusions.
We shall start by describing in detail the architectural design of
the PICARD framework, its modules, and their semantics.
2. Materials and methods: the PICARD DSS engine
2.1. The PICARD DSS engine architectural design
In this section we will describe the architecture of PICARD DSS
engine. We start by showing the high-level architecture, and then
its internal architecture and components.
2.1.1. The overall PICARD DSS engine architecture
Fig. 2 describes the overall architecture of the PICARD DSS
engine and its components, which are designed as a Service Ori-
ented Architecture (SOA)2 (i.e., each of its components might exist
on different servers, anywhere on the web). Note that the figure is
an instance of Fig. 1; however, The PICARD DSS engine is linked to
the local electronic medical record through a temporal reasoning
service that answers its queries, when needed, regarding the
patient’s data or their interpretation; and to the GL library through
the GL knowledge services, which provide the relevant GL knowl-
edge. At the core of that architecture, sits the GL-application engine,
the PICARD DSS engine (component #2 in Fig. 2), which is responsible
for applying the GL. The client application and users layer (compo-
nent #1 in Fig. 2) defines several types of service-users and devices.
Each human service-user represents an actor who is directly influ-
enced by the functionality that the PICARD DSS engine offers: (1)
patients at home who can connect via a mobile device or a website
to obtain personalized recommendations; (2) caregivers such as
physicians or nurses at the point of care who receive alerts, or
who are at a medical call center that and receive therapy recommen-
dations based on telemedicine data; (3) knowledge engineerswho use
the service to debug the PICARD DSS engine, e.g., by detecting its
logs, or use a simulation engine to perform simulation on GL scenar-
ios. In addition, the architecture includes a service that accesses the
GL knowledge library to retrieve procedural (workflow, or ‘‘how-to”)
knowledge and declarative (interpretation, or ‘‘what-is”) knowledge
(component #3 in Fig. 2), and a service that accesses the temporal
reasoning engine, which analyzes the patient’s longitudinal clinical
data and interprets them in the light of the GL-specific declarative
knowledge (component #4 in Fig. 2).
2.1.2. The internal PICARD DSS engine architecture
Fig. 3 presents a detailed view of the PICRAD DSS engine. It con-
tains five main components:
(1) Client Application Interfaces (APIs);
(2) the guideline application unit, which is in fact the core
engine, and which performs synchronous (user-driven)
tasks;
(3) the internal monitoring unit, which operates continuously,
and which performs asynchronous (data-driven) tasks;2 A Service Oriented Architecture (SOA) is a set of principles and methodologies for
designing and developing software in the form of interoperable services.
Fig. 2. The overall PICARD DSS framework architecture, designed as a Service Oriented Architecture (SOA). Arrows denote the flow of data, knowledge, queries, or
recommendations.
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data layer, and to the external services such as the knowl-
edge, and the temporal reasoning services; and
(5) the data layer, which stores the data repositories, such as a
log file of the PICARD DSS application, and the complemen-
tary data base (DB), which stores the recommendation
results.
The internal monitoring unit interacts, through the ‘‘Access to
external data and knowledge services” module, with the external
monitoring process that is performed by the temporal reasoning
services (Fig. 3), as we explain in detail in Section 2.5.2.2. The client APIs
The PICARD DSS engine supports a set of APIs to allow different
types of client devices to interact with it, depending on the client’s
task type. For example, one API can transfer robust data to a med-
ical administrator who wishes to debug the engine, while another
can provide a much lighter-weight interface for a patient’s mobile
phone. Each client application must implement one of the APIs to
interact with the PICARD DSS engine. All of the task-specific APIs
co-exist in this layer and are accessible through web or Local Area
Network protocols, thus answering requirement #4 in Section 1.1
(provision of support through different APIs).
We assume at least three different interactive-task types: (1) GL
debugging, (2) GL simulation, and (3) real-time GL application (i.e.,
enactment of the GL). For example, a GL-debugging task might
include a client application that is specific for use by a knowledge
engineer and that depicts the detailed state of the GL application
engine at each step; a GL-simulation application might be a soft-
ware component without any graphical interface, such as a simu-
lation engine that simulates and tests over time the behavior of
the GL-application engine on a simulated longitudinal patient
database; and GL-application tasks include, for example, a desktopdecision-support application for the medical staff at the point of
care, or an advisor for patients who are using their mobile phone.
Each client application interacts differently with the PICARD DSS
engine, depending on the client’s task type, using a dedicated task
specific API. The request is than delegated to the GL application
unit, which handles the call according to its logic (see Section 2.4.1
for more details regarding the types of recommendations that are
generated through this API).
For example, Fig. 4 shows an example of the application log in
user interface for the debugging mode, using the debugging
PICARD DSS engine API. Each node in the application log is an
applied plan. Each plan has a name, instance ID, GL ID, current state
transition and start time. This user interface helps the knowledge
engineer to debug the application of the PICARD DSS engine.2.3. The guideline-application unit
The PICARD DSS GL-application unit contains the core engine
and performs synchronous (user-driven) tasks through the GL
application API, and asynchronous tasks (data-driven) through the
monitoring unit. The engine applies GLs based on the AsbruGL spec-
ification language [31] which has a very rich formal structure. In
particular, Asbru has an expressive representation for repeating
plans and for monitoring conditions (for example, an abort condi-
tion or complete condition), which is essential to apply to GLs over
time. An Asbru GL is composed of multiple knowledge roles, such as
filter condition (compulsory eligibility constraints), complete condi-
tion (constraints on ending the plan), or plan-body (the actual proce-
dural aspect). The core semantics and functionality of the GL
application unit are built on top of the Spock engine [7], which
was designed and implemented in a previous study for applying
guidelines written in an extended version of Asbru, Hybrid-Asbru.
The Hybrid-Asbru representation was designed to support several
increasingly formal levels of representation, from semi-structured,
through semi-formal, and up to a completely formal, executable
Fig. 3. The PICARD DSS engine’s internal architecture. See Section 2.3 for the
internal structure and functionality of the Guideline (GL) application unit, and
Section 2.5 for the internal monitoring unit. Note that the internal monitoring unit
interacts, through the ‘‘Access to external data and knowledge services” module,
with the external monitoring process performed by the temporal reasoning
services.
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describes in Section 1.1, we have significantly modified the
Hybrid-Asbru representation, as described by the information
model depicted in Fig. 5: A Hybrid-Asbru GL is decomposed into
(sub)plans. Thus, for each plan that participates in the application
process, a corresponding plan-instance object is instantiated. TheFig. 4. The user interface for debugging the afirst plan-instance object created in each GL application is the root
plan-instance, which stores all of the application’s details, such as
the selected GL for application, the patient and the care provider.
Each plan instance contains either recommendations for actions
(i.e., an action step) or decision nodes (i.e., a decision step). Thus,
the engine provides two types of plan-steps: (1) action-steps that
are intended to be performed (e.g., order a laboratory test), and
(2) decision-steps (e.g., if-then-else) which might result in an addi-
tional plan-step. During the application, a plan-instance may have
one or more state transitions according to the Asbru state-
transition rules. As the application of the GL proceeds, one or more
plan instances are created for every Hybrid-Asbru plan that partic-
ipated in the application session. Each plan has one or more steps
which are recommendations or decision steps that can be presented
to a user (such as recommending a drug or making a decision), and
one plan-body of type single-action, cyclical (periodic), or sub-plan.
The collection of plan-instance objects is organized as an intercon-
nected network enabling state transitions of (sub)plans to be prop-
agated downwards or upwards, as appropriate. Note that we added
a new type of plan-body called MonitorPlan. The semantics of this
type will be explained in Section 2.4.3, however, modifying the
Hybrid-Asbru representation answering requirement #1 (support
continues guideline application) and requirement #3 (support
asynchronous application).2.4. Modifications to the Hybrid-Asbru knowledge schemas
While developing the PICARD architecture as a network of scal-
able server-based components, we noted that there are several
additional preliminary issues that must be considered in the initial
phase of GL specification, and must be reflected in PICARD’s design,
in order to later apply the GL in a more realistic fashion. These
modifications (to the Hybrid-Asbru schema and its implementa-
tion within the Spock architecture) include modifying the procedu-
ral knowledge schema and the declarative knowledge schema, and
the data structure, as follows:2.4.1. Modification #1: Differentiating between different types of
recommendations
The motivation for modification: A major task for any GL inter-
preter is to issue specific GL-based recommendations, which the
PICARD DSS engine does whenever a clinical step becomes active
(in Hybrid-Asbru semantics, a clinical step is a leaf plan in the
plan-tree, i.e., a plan that cannot be further decomposed).
The modification’s implementation: To better support require-
ment #2 in Section 1.1, we modified two different aspects of Asbru
plan and action semantics: (1) An explicit representation of the
recommendations’ semantics, which we describe in this sub-
section, and (2) An explicit verification, in the EMR, that thedvanced API of the PICARD DSS engine.
Fig. 5. The updated information model of the PICARD system, built on top of the SPOCK system. Note that we have added new type of plan-body called MonitorPlan which is
circled by a dashed line. See Section 2.4.3 for a detailed explanation of the motivation and implementation of the new Plan Body type.
E. Shalom et al. / Journal of Biomedical Informatics 59 (2016) 130–148 135recommendation has indeed been carried out, which we describe
in the next sub-section.
We started by modifying the plan-activation knowledge-role,
by distinguishing between two types of clinical steps:
1. Patient-data-entry. This step represents a sensing (i.e., get-data)
recommendation, used to capture user data. Each patient data-
entry item has a type, such as numeric, Boolean, textual and
date-timewhich used to define the type of input. In addition, each
step (e.g., ‘‘measure the systolic blood pressure”) has a unique GL
ID; andeach termwithin it (e.g., ‘‘systolic blood pressure”) option-
ally has one or more concept IDs from standard vocabularies (e.g.
SNOMED CT) to support the integration of the system itself with
existing systems or with local electronical patient records.
When a patient-data-entry item becomes active, the PICARD
DSS engine sends the temporal reasoning engine a request to check
whether the concept ID of the item already exists in the longitudi-
nal EMR, and whether it is still valid according to the concept’s
Good-for declarative-knowledge property, which is stored in the
declarative KB, such as its half-life of validity (e.g., ‘‘Is the value
of the blood pressure measurement from two hours ago still valid
in the GL’s relevant context?”).3 If an entry for the item already
exists in the EMR and its value is still valid (e.g., a valid blood-
pressure measurement, or a previous data entry with a ‘‘True” truth
value for the question ‘‘did the patient have diabetes in the past”),
the PICARD DSS engine might retrieve its last valid value through
the temporal reasoning engine, and attach it to the requested item,
or skip the recommendation altogether by transitioning its Asbru
state to a complete state (a choice that is defined as a property of
the clinical step). However, if a value for the item does not exist in
the EMR, or if it exists, but is no longer valid, the PICARD DSS engine
sends this item to the client application, through the client API, with
a request to fill in the data according to its type. This request for a3 The declarative knowledge base includes both the Good-for and the Good-Before
declarative properties, since the persistence of the value both before and after it was
measured is necessary for correct operation of the temporal reasoning engine. The
persistence depends on the value, the duration of the interval over which the value
was known to be true, and on the context.data value will remain in its active state until its timeout (and then
it switches to an abort state), or until its parent plan is aborted or
completed. If this data entry must have a value before ending and
it is aborted, its parent plan will also be aborted, possibly because
the GL was not specified correctly. Therefore, usually data-entry
requests are not forced to wait for a closing value.
In the client application, the query can easily be converted into a
Graphical User Interface (GUI) control. For example, a Boolean type
can be converted into an option box. Table 2 shows examples for
each data type and examples of its conversion into a GUI widget.
Note that not all of the data that are needed for GL application
exist in the EMR. However, during the knowledge acquisition
phase, the expert might know in advance if a data item will exist
or not in the clinical data repository when needed by the PICARD
DSS engine. (For example, the concept ‘‘number of sexual part-
ners”, a piece of data required by a Pelvic Inflammatory Disease
guideline, is not likely to be registered in the EMR; even whether
the patient is a smoker might not be listed.) Thus, by adding explic-
itly the attribute ‘‘does not exist in the EMR” for a particular concept
in the knowledge base, the response time of the application might
improve, since there is no need to search for the value of such a
concept in the EMR, and the user can be immediately queried for
its value. Of course, the expert might not be sure if the item will
exist in the EMR; the default is therefore ‘‘Exists in the EMR”.
2. Procedure. This step represents an [Asbru] action that the user
should accept or decline. Each procedure has a type, a name
and a unique GL ID (and again, optionally one or more IDs of
standard vocabularies). Table 3 describes the current complete
list of the different types of procedures. These types are defined
in the GL specification phase.
The flow and logic of how the PICARD-DSS engine handles rec-
ommendations is described in Section 3.1.2.4.2. Modification # 2: Verifying adherence to the recommendations
The motivation for modification: One of the aspects of realistic
application is to verify that, whenever possible, the recommenda-
tions are actually adhered to, and that, in particular, the
Table 2
The different types of patient-data-entry recommendation.
Data
type
Description Example GUI widget
Numeric To capture numeric
values of used data
‘‘Please enter your pain
level from 1 to 10”
Text box/list
of numbers
Boolean To ask a yes/no
question
‘‘Has the patient lost
weight?”
Option box
Textual To capture text ‘‘What did you eat
today?”
Text box
Datetime To capture date or
time items
‘‘What time did you
take your last pill?”
Calendar
Table 3
The different types of procedures.
No. Name Description Example
1 Directive An administrative
action
Admit the patient to ward
2 Referral A referral to
expert
Refer the patient to a dietician
3 Procedure A medical
therapeutic
procedure
Insert a catheter into the patient
4 Observation Perform an
observation
Check for blurred vision of the
patient
5 Take History Perform an
anamnesis
Check if the patient smokes
6 Physical
Examination
Usually clinically
measured
Check the patient’s blood
pressure
7 Drug
Prescription
Prescribe a drug Prescribe Coumadin (Warfarin)
to the patient 3 times a day
8 Drug
Administration
Administration of
a drug
Administer Hydralizin 3 times a
day for 2 days
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Section 1.1, requirement #2 suggests that actions such as
performance of laboratory tests, physical examinations, and acqui-
sition of patient history or even application of medical therapeutic
procedures be validated by ascertaining that these actions have
actually been performed. the verification of a procedure applica-
tion by the user is achieved by (1) making sure that the procedure
code has appeared in the EMR, or at least, especially in the case of a
recommended clinical observation or a laboratory test, that the
user has accepted the recommendation (note that a significant time
lag might exist from this acceptance until the value of the test
actually appears in the EMR), and (2) by explicitly representing
in the declarative knowledge base, when relevant, the value of
which concept should eventually appear in the EMR as a result of
each procedure within a procedure-specific time frame that is
also predefined in the knowledge base. Thus, a blood-pressure
measurement action must lead to the actual appearance, within a
pre-specified [in the knowledge base] temporal window, of a
new blood-pressure value in the EMR; an insulin injection
recommendation that is accepted must be followed by the eventual
appearance, within some pre-specified temporal window, in the
EMR, of an Insulin Injection procedural code. Only then is the action
Completed (and not just Accepted by the user). Thus, Accepted is an
intermediate state of an Asbru action (technically, within the Active
state) before being Completed. (Note that an action can also be
Declined, a sub-type of the Aborted state.)
For example, the recommendation to measure blood pressure
will only be completed (in the sense of an Asbru plan complete
transition) when the user accepts the recommendation and the val-
ues of both the systolic and the diastolic pressures exist in the EMR
within a pre-specified time delay.
In the case of an intervention without an outcome value, we
expect the code of the procedure to eventually appear in theEMR within some reasonable delay. Thus, for example, in the case
of the therapeutic procedure ‘‘insert catheter”, only when the code
of the procedure and its time of performance appear in the EMR
within a pre-specified time delay, can it be fully completed. There-
fore, until its expected result actually exists in the EMR, each
applied plan is still active, in the Asbru sense.
The modification’s implementation
1. For each specific procedure type there might be a typical (i.e.,
default) procedure duration – a ‘‘reasonable” period within
which it is expected to be carried out (e.g., the time it might
take to actually measure the blood pressure), and a typical
EMR procedure-result report-time delay – a reasonable period
within which the result of the procedure should be documented
in the EMR (e.g., the systolic blood pressure).
We also allow for a typical procedure set-up time, measured
from the time that the user accepts the recommendation provided
by the PICARD DSS engine until the procedure is actually initiated
(see Fig. 6). These properties are somewhat akin in nature to the
Good-for (i.e., forward persistence) declarative property of most
measureable concepts, which was described previously, namely,
the time after measurement during which their measurement is
valid; all are inherent properties of the procedure type. To store
these properties, we have extended the procedural knowledge base
by adding the temporal properties of the procedural concepts to
the declarative knowledge base, although they can be overridden
when specifying a particular guideline.
2. We had have enhanced the Hybrid-Asbru schema so that each
recommendation can be optionally assigned a pre-reminder
time, to remind the user of the forthcoming procedure-
application time, a result-entry reminder time (at some point
Fig. 6. The life cycle of a procedural recommendation made by the PICARD DSS engine.
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the user of the fact that a value documenting the result of the
procedure needs to be entered, if it has not already appeared
in the EMR, and a procedure result-entry post-reminder time, to
alert the user to the fact that no procedure result has been
entered at the expected result-reporting time.
The special procedural properties are exploited by the PICARD
DSS engine by using the temporal reasoning engine, which can
directly access the longitudinal medical record.
Fig. 6 describes the life cycle of a typical recommendation in the
PICARD DSS engine: For example, a (possibly periodic) blood-
pressuremeasurement procedure is recommended at t0, and accepted
at some point t1; it might optionally be preceded by a pre-reminder
5 min before themeasurement, at t1. Thus, at t0, a recommendation
is sent tomeasure themorning blood pressure. Once the user accepts
the recommendation, a fiveminutes set-up time is expected until the
blood pressure measurement is actually initiated at t2.
The measurement itself should be completed by t3, within a
procedural duration time of three minutes, but an additional
10 min result-reporting delay until t5 is allowed for, i.e., until the
value of the systolic and diastolic blood pressures should be
entered in the EMR. A result-entry reminder might be triggered
at t4, four minutes before the end of the result-entry deadline. If
no entry has been recorded, an alert regarding a missing blood-
pressure result in the EMR might be sent five minutes after the
result-entry deadline, at t6.
Note that each of the resulting values (the systolic and diastolic
blood-pressure value concepts) is valid (Good-for) for threehours fol-
lowing the completionof its actualmeasurement at the valid-time t3,
whichwill be documented in theEMRwhen it is enteredat the trans-
action time t5 (or for any other valid time period, depending on the
context in which the blood-pressure measurement procedure is
being applied, as defined in the declarative knowledge base).
3. In addition to its use by the temporal reasoning engine to cor-
rectly interpret longitudinal clinical data (e.g., to correctly form
time intervals over which some concept value held, from sev-
eral discrete time points), another reason that the Good-for
value–validity period property is important is that, as explained
previously, the PICARD DSS engine might decide to not recom-
mend a sensing action, such as a blood pressure measurement,
if its last-measured (or acquired) value is still valid. One possi-
ble scenario is that the value was acquired by other means, out-
side of the current GL; for example, another nurse had
measured the blood pressure and recorded it in the patient’s
EMR just a few minutes before the procedure was supposed
to be performed by the patient’s attending nurse.
Note that this is an interesting use of the Good-for declarative-
knowledge property, referred to in knowledge-based temporal-
abstraction theory [32] as local persistence [33], which is usuallyused by the temporal reasoning engine to generate interval-
based temporal patterns. Here, we are using this declarative prop-
erty for a purely procedural aspect of the measured value.
However, there are certain recommendations that involve pro-
cedures whose results cannot or should not be validated for the
procedure to be completed. For example, the recommendation
‘‘consider other causes for pre-eclampsia,” or a recommendation
that concerns acquisition of data that do not exist in the EMR
and that might not exist in it after the procedure either, such as
asking the patient if he or she smokes. In addition, sometimes there
is a need for manual confirmation of the recommendation, such as
the start of a plan, without any further validation. For example,
before switching to a severe treatment plan for eclampsia, a manual
confirmation by the physician is required. (The confirmation itself
is stored by the PICARD DSS engine in the log; so in a sense, it
serves as its own validation.) We store an indication, as part of
these procedures’ properties, that no value needs to appear in
the EMR to complete (in the Asbru sense) the performance of such
procedures, thus answering requirement #2.2.4.3. Modification #3: Supporting asynchronous application
Motivation for modification: The Asbru language supports mainly
a synchronous application. Specification of an asynchronous guide-
line requires significant ingenuity on behalf of the knowledge engi-
neer, and is practically impossible for a domain expert or a clinical
knowledge editor, although both of these agents play crucial roles
in maintaining the GL knowledge [8]. A full implementation of an
engine supporting such a code is a challenging task by itself, even
assuming that a correct specification is available.
The modification’s implementation: In order to support more
directly the specification and implementation of an asynchronous
GL application, we added an ‘‘asynchronous” plan as a ‘‘first class
citizen” to Asbru’s single action plan-body with the notion of <trig-
ger, Action>.
Fig. 7 shows an example of Hybrid-Asbru monitoring plan as
part of the severe preeclampsia/eclampsia/toxemia (PET) GL we
have formalized [34]. Note that its trigger is either severe PET or
eclampsia. When it is triggered asynchronously, the ‘‘management
of severe PET” plan is activated. When the PICARD DSS engine
applies the monitoring plan-body, it sends the trigger condition
to the internal monitoring unit, thus answering requirement #3
in Section 1.1.2.4.4. Modification #4: Simplifying the syntax and semantics of
periodic plans
Motivation for modification: Because the acquisition of cyclical
(i.e., repeating) plans is one of the keys for specifying a continuous
GL, we have slightly simplified the syntax of Asbru’s cyclical plan
(as defined essentially in Shahar et al.’s 1998 Artif. Intell. in Med.
paper [31] and Miksch et al.’s 1997 KEML paper [35]), by reducing
the number of its elements, on one hand, while, on the other hand,
Fig. 7. A simplified example in XML of a monitoring plan.
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of the plan.
The former definitions included several redundant properties of
elements such as ‘‘cyclical-time-annotation” for the start time,
repeating specification, ‘‘cyclical-complete-condition” and ‘‘maxi-
mal number of attempts” [36] (for example defining the
time-annotation for the default of the plan and also to the
cyclical-plan-body, or defining a complete condition to the plan
and also to the cyclical-plan-body). This redundancy made the
knowledge acquisition task highly complex, especially when in for-
mer research we showed the difficulty of clinical editors to specify
and understand Asbru’s cyclical plan [9].
The modification’s implementation: In this simplified model, each
cyclical plan has only a repeating step and periodicity. A repeating
step can be any single action such as administration of a medica-
tion or a plan pointer and can have a time annotation to allow,
for example, a step to start after an hour. The repetition properties
are defined in the repeating specification element of several types:
cardinality (e.g., exactly 3 repetitions), a calendar repetition (e.g.,
every weekend), or an absolute-gap repetition which defines the
gap between the repetitions (e.g., every hour). Fig. 8 describes
the revised schema of the cyclical plan, thus answering require-
ment #1 in Section 1.1.2.5. The internal monitoring unit
The internal monitoring unit handles asynchronous events and
constantly monitors monitored items.Fig. 8. The modified schema of a hybrid-Asbru cyclical (periodic-action) plan. The ‘‘cycl
details). The ‘‘repeating specification” represents the step should be repeated such as spec
time-gap) or specific calender time such as every weekend (calendary periodicity).There are two types of monitored items:
(1) Internally monitored items – these items, such as the start-
time of a scheduled plan, are monitored and managed exclu-
sively by the internal monitoring unit; thus, whenever some
criteria are evaluated to a truth value, the internal monitor-
ing manager notifies the controller about the event.
(2) Externally monitored items – these items, such as the
appearance in the EMR of an expected result of a sensing
action, include patterns that the external temporal reason-
ing engine, part of the external temporal reasoning services,
is monitoring in the patient’s record, to which the internal
monitoring manager subscribes; these items reflect actual
clinical reality. When a pattern, consisting of certain prede-
fined criteria, is evaluated to a truth value of True by the
temporal reasoning engine, that engine triggers a message
back to the internal monitoring manager, according to the
appropriate subscription. The internal monitoring manager
then notifies the GL application unit about the event of
detecting the patter, which resumes the GL, and continue
to apply it, thus answering requirement #1 (support contin-
ues guideline application). Table 4 summarizes the different
monitoring item types.
In order to ensure a continuous link between the GL application
unit and the monitoring unit so that no message gets lost, we used
a queue on each side so that if some component was down, the
queue stored its messages until it was up again. In addition, eachical plan details” element represents the step that should be repeated (clinical step
ific repetition number (cardinality), constant time-gap between repetition (absolute
Fig. 9. An example of the implementation of an explanation for the procedural recommendation ‘‘we suggest administering valium 5–10 mg IV” when the user clicks on the
link ‘‘explanation for the recommendation”.
Table 4
The different monitored item types.
Type Monitored item type Description
Internal Start time of plan Start time of a scheduled plan is triggered
End time of plan If plan has a duration, end time of a scheduled plan is triggered
Start time of the first repetition of a
periodic plan
The time for first repetition is triggered
Time of next repetition of periodic plan The time for the next repetition is triggered
External Monitored plan condition The asynchronous condition of the monitoring plan is evaluated to True
Notification to client Sends notification to the client
The appearance of a result for a data item
in the patient’s record
When a recommendation is accepted by the caregiver and it is expected to appear in the DB, another
monitoring item is initiated to monitor the appearance of the result in the patient record
Asbru’s monitored conditions Asbru plan-control conditions such as the set-up condition, abort condition suspend condition, reactivate
condition or complete condition of a plan
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tion is stored in a log with a time stamp for tracing. After the mon-
itor item gets to its final state, it is no longer used by the system.
2.6. The Picard DSS explanation mechanism
Recall that one of the requirements for realistic GL application
presented in Section 1.1 was to provide explanations for the rec-
ommendations of a DSS. Thus, each alert and recommendation pro-
vided by the PICARD DSS engine has to be followed by a reasonable
explanation.
To answer this requirement (requirement #5), we had devel-
oped an explanation generator as part of the application engine.
The explanation always starts with the phrase ‘‘According to the
current ⁄GuidelineName⁄ guideline,. . .” (where GuidelineName is
the current GL’s name).
There are two types of explanations:
1. A Declarative explanation – the source of declarative explana-
tions, regarding interpretations of clinical data, is the media-
tor, which has passed the explanation, actually coming from
the declarative KB (see Section 1.1) to the PICARD DSS
engine.
2. A Procedural explanation – the source of a procedural expla-
nation for single or repeating recommended actions is the
PICARD DSS engine itself. For example, in the case of a peri-
odic plan, the pattern of the recommendation is: ‘‘⁄Test
Name⁄ should be performed ⁄CyclicalPlan.Frequency⁄ and this
is the ⁄Current Iteration Number⁄ time.” This explanation is
generated using the procedural (workflow-oriented) knowl-
edge (see Section 1.1). For example, the explanation for the
first of the three blood pressure (BP) daily tests is ‘‘BPshould be performed three times a day, and this is the first
time.”
Fig. 9 shows an example of a possible explanation for the proce-
dural recommendation ‘‘we suggest administering valium 5–10 mg
IV.”2.7. The services access layer
The access to services component includes two types of internal
services: (1) Log and persist services – responsible for logging and
tracing the application session and state transitions (e.g., transit
from state Activated to state Aborted) of the applied plans. (2) Com-
plementary DB services – to log all answers to all requests for infor-
mation from the user, thus building a complementary DB to the
EMR, and (3) External services to access the temporal-reasoning ser-
vices, which responsible for the retrieval of inferred results from the
temporal reasoning engine, and to the procedural knowledge library,
responsible for retrieval of procedural knowledge from the knowl-
edge services.2.8. The data layer
This layer includes twomain repositories: (1) Logandpersistence
to for logging and tracing the application engine’s internal states,
and (2) complementary DB to store the recommendation results,
and the acquired patient data from the client when data needed
for GL application do not exist in the EMR. This repositories are use-
ful for explanations as explained in Section 2.6, and for tracing
PICARD DSS engine outputs, thus answering requirement #5 in
Section 1.1.
Table 5
The main use case: get recommendation.
Use case: Get recommendations
Brief description Manage an existing GL-application session for a patient
Primary actors Caregivers, patients, knowledge engineers
Secondary actors DEGEL, temporal mediator and PICARD DSS log
Pre-conditions All actors are registered
The GL to apply exists in DeGeL
Main flow 1. The use case starts by sending a request for a recommendation to the PICARD DSS
2. If the request is to start a new application session for a patient (the application mode of the request is set to ‘‘Init session” mode)
2.1. Handle start app session
2.2. Log request in the PICARD DSS log
2.3. Create and store the application tree in memory
2.4. Set application mode = ‘‘get recommendations”
3. If the request is to resume a new application session for a patient (the application mode of the request is set to ‘‘resume session” mode)
3.1. Handle resume app session
3.2. Get last session from the PICARD DSS log
3.3. Load and store the application tree in memory
3.4. Set application mode = ‘‘get recommendations”
Else
4. Handle user responses
4.1. Get user responses
4.2. Apply GL – at any time of GL application
4.3. Get GL knowledge from DeGeL
4.4. Send queries to the temporal mediator
4.5. Save and log the GL application session unit (internally)
4.6. If the session is ended, set application mode = ‘‘ended”
At any time: get asynchronous results from the temporal mediator
At any time: get asynchronous events from the engine’s monitor
5. Send recommendation and alerts to the user
5.1. Synchronously at the end of 4.5
5.2. Asynchronous at any time
6. If application mode = ‘‘ended”
6.1. Show end the session message
6.2. Send a confirmation to the engine (application mode = ‘‘ended”)
Else
6.1. Show the recommendation and alerts to the user
6.2. Send user responses to PICARD DSS (application mode = ‘‘get recommendations”)
Post-conditions The user gets recommendations and alerts episodically
Alternative flows None
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We implemented the Client APIs with several web-based client
interfaces connecting through the Microsoft Windows Communica-
tion Foundation (WCF) module [37] to the PICARD DSS engine. At
the back-end, we used additional WCF services to communicate
between (1) the GL application unit and the monitoring unit, (2)
the PICARD DSS engine and the temporal mediator, (3) the PICARD
DSS engine and the knowledge base, and (4) the PICARD DSS
engine and the data layer. All components are installed on different
servers, accessed by services.
As to the implementation choice for specific components: Since
we had rigorously evaluated our Digital Guideline Electronic Library
(DeGeL) architecture [6–9,38], we used it to retrieve procedural
GLs and specific declarative knowledge items when applying GL
with the PICARD DSS engine. Similarly, we used a variation of the
IDAN temporal-abstraction mediator [39] to answer guideline-
specific temporal-abstraction knowledge-based queries to the
time-oriented clinical data. Finally, to provide access to an existing
EMR we used MEIDA medical-data access system [40].3.1. The PICARD DSS engine’s main functionality
Table 5 describes the main use case of the GL-based-care sys-
tem which uses the PICARD DSS engine, namely the ‘‘get recom-
mendation” use case (from the point of view of a client), while
Fig. 10 describes it as a sequence diagram. This use case manages
a new application session, continues an existing application or
resumes a previously applied one. The interaction between the cli-
ent application and the engine is episodic, i.e., a synchronoussequence of request–response. However, at any time, the monitor-
ing unit or the mediator, which is listening to asynchronous events,
might notify the PICARD DSS engine when one of the asynchronous
plans is triggered. During an application session, the engine uses
the DeGeL library to retrieve the GL procedural knowledge and
the temporal mediator to subscribe to triggers of asynchronous
plans. All of the data during the application session is saved within
the PICARD DSS engine’s log.4. Examples of preliminary deployments of the PICARD DSS
engine
In this section, we briefly describe two specific applications that
we had developed in several different domains, using the PICARD
DSS engine, which demonstrate different aspects of that architec-
ture, as well as its general feasibility.
4.1. The cardiology domain: Monitoring patients in a telemedicine
setting
This client application was developed as a prototype for a tele-
medicine call center in which trained nurses can modify doses of
drugs such as the Coumadin (Warfarin) anti-coagulant. For the
patient at home, we had developed a mobile client application.
The patients can use it every day, or whenever necessary, to trans-
mit their weight, heart rate, and their systolic and diastolic blood
pressure measurements to the call center via a telemedicine sys-
tem (see Fig. 11). This application demonstrated the asynchronous
mode of the PICARD DSS engine: the patient’s data are constantly
monitored, and when the patient is eligible to one or more GLs, a
Fig. 10. A time-sequence diagram of the ‘‘Get recommendation” use case.
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tion of the framework using 73 enhanced patient records, 36
potential scenarios of treatments of the Coumadin GL, and several
specific complex cases that were embodied within the patient
records. All sample cases were applied correctly by the PICARD
DSS engine, as confirmed by the health-maintenance organiza-
tion’s senior cardiologist, who served as our main domain expert.4.2. The European Union’s 7th Framework MobiGuide project
Based on the experience we had gained, the PICARD DSS engine
is currently serving as the backbone of the European Union’s 7th
Framework MobiGuide project [41]. The main objective of the
MobiGuide project is to develop a distributed patient guidance sys-
tem that integrates hospital and monitoring data into a Personal
Fig. 11. The chronic heart failure (CHF) call center dashboard. The nurse consultation ‘‘dashboard” is shown on the left. The patient’s time-oriented data visualization tool
appears on the right.
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provides personalized, secure, clinical-guideline-based guidance to
the patients and to their care providers, both inside and outside
standard clinical environments. In this project, we have chosen
to split the architecture into two main components: a central
back-end DSS (BE-DSS) residing on a server system (this could be
a cloud server, or, as in our case, on-premise servers in hospitals),
and a mobile DSS (mDSS) residing on the patient’s mobile device,
which can be viewed as an extension of the Picard DSS residing
on the mobile device. The local mDSS components are necessary
to distribute computationally intensive monitoring and decision-
making processes, with respect to data and knowledge require-
ments, at the local device level [42,43]. Thus, The PICARD DSS
engine sends the patient alerts as necessary, and provides person-
alized guideline-based recommendations to their care providers,
using sensors on the patient, or at the patient’s home, and the
patient’s mobile devices. The interaction with the sensors, as well
as the broadcasting of the data to the patient’s medical record
(and thus, implicitly, to the PICARD DSS engine) is made through
the patient’s mobile device, and a series of backend servers. Note
that the semantics of each action in the GL remain the same; the
difference is mainly regarding which DSS, the central (BE-DSS) or
the local (mDSS) one, actually performs the action. The precise
fashion in which the BE-DSS and the mDSS engines are coordi-
nated, and the policy we use to determine during GL representa-
tion as to when and how to split the responsibilities associated
with the GL among the two engine, are out of the scope of the cur-
rent paper. However, the distributed architecture and the distribu-
tion policy are described in detail elsewhere [42,43].
The MobiGuide project demonstrates the flexibility of the
Picard architecture, which manages in this project guidelines from
several different clinical domains. The application also demon-
strates the capability of supporting the decisions of several actors
(physicians, patients) and of applying asynchronous (data driven)
plans.
We will now describe the detailed technically oriented and clin-
ically oriented evaluations we had performed on the PICARD DSS
engine.5. The evaluation methods
We performed three separate, consecutive evaluations; all three
evaluations were performed in the OB/GYN domain, using aeclampsia/toxemia (PET) GL of the American College of Obstetrics
and Gynecology (ACOG) that was popular at the time of the study
[34].
(1) A technical evaluation in a complex clinical domain, using a
set of GL-based simulated clinical scenarios and longitudinal
records, in order to validate the PICARD DSS engine, and
ensure that the integration between the PICARD DSS engine
and the overall guideline-based-care framework is feasible.
(2) A functional evaluation in the same domain, generating six
realistic clinical scenarios and testing the validity of the
PICARD DSS engine’s recommendations and explanations
in these scenarios with the assistance of several senior
domain experts.
(3) A clinically oriented evaluation in the same complex clinical
domain, using the same six realistically simulated longitudi-
nal patient records and multiple assisting clinicians, to fully
assess the potential impact of such a framework on the clin-
icians’ decision-making behavior.
Note: for the purpose of the various evaluations, we combined
in the declarative KB the set-up, duration, and result-entry delay
times of each of the recommended procedures into one overall pro-
cedure result-reporting delay period, since the entry of the result
was simulated in any case by us. Furthermore, for the purpose of
the evaluations, at runtime, we entered in the EMR a simulated
appropriate result value for each procedure accepted by the user,
thus enabling the procedures to be completed in the Asbru sense.
5.1. The technical evaluation
The technical evaluation assessed the technical aspects of the
architecture, and in particular the feasibility of the PICARD DSS
engine to apply multiple plan-instances concurrently, including
instances that are cyclical and asynchronous, including monitoring
and triggering of all monitored conditions and asynchronous
events. Also, it tested the level of integration of the overall frame-
work’s components (such as the internal monitoring unit, and the
mediator, as well as the services to the KB and to the data
repositories).
As part of this evaluation, we used a specialized GL-based sim-
ulation engine [44] to generate and run 19 GL-based theoretical sce-
narios, or possible pathways through the GL (in this case, the PET
GL), which were computed by the engine as legal combinations
Table 6
The different parameters for the application cardinality of GL scenario.
Parameter name Description Explanation
The number of knowledge
roles (KRs) when the GL is
represented in Asbru
Each Asbru-GL is composed of several KRs (e.g. eligibility
criteria)
Some of these KRs might be ‘‘artificial” KRs such as Asynch, Sequential
or Parallel Sub-plans KRs, which are not concrete and are used to group
several sub-plans, or might be concrete KRs, such as Single Action
which is used for example to recommend a specific action. Thus, the
more ‘‘artificial” KRs and different types of KRs the scenario composed
of, the higher its complexity
Asbru plan-instances created
at run time
Each application session creates a plan-instance trace in the
PICARD DSS log
The more plan-instances are created, the higher the application
cardinality of the scenario, because the engine applies a large number
of plans of different types
Monitored items The internal monitoring unit is responsible for monitoring
and triggering due to internal and external events
As the number of items triggered and monitored by the monitoring
unit increases, the application cardinality of the scenario
Simulated data transactions A set of simulated longitudinal records, each composed of a
set of simulated transactions (e.g., a single blood test), is
generated for each scenario
As more data transactions are simulated on average per scenario, the
total application cardinality of the GL’s instantiated scenario increases
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[Abort condition = False] \ [Complete condition = True]). (The
number of possible paths might be considered as a measure of
the GL’s inherent complexity.) In addition, to determine whether
the PICARD engine can handle guidelines at several levels of diffi-
culty of runtime application, we defined several parameters to esti-
mate the total application cardinality of each instantiated scenario,
i.e., a theoretical scenario applied for a particular set of data and
time duration, described in Table 6.
Thus, each GL-based instantiated scenario could be said to be
characterized by some degree of total application cardinality, com-
posed of multiple aspects, which includes the number of knowl-
edge roles, plan instances, monitored items, and data items used
during the application of the scenario (see Table 6). Note that the
total application cardinality of an instantiated scenario is affected,
of course, by its duration, as well as by the inherent characteristics
(e.g., number of different steps) of the GL pathway that it
represents.
Fig. 12 shows the technical evaluation process: The simulation
is done by the knowledge-engineer who simulates records for con-
tinuous time (step 1), and then runs several sets of clinical scenar-
ios without involving clinicians or a user interface as in the
experiment phase (2). During this simulation, the knowledge-
engineer assesses the PICARD DSS engine’s log, i.e., the recommen-
dations and the time they are generated compared to the gold-
standard GL (step 3).
To assess the performance, we defined two main measures: the
correctness, i.e., the portion of correct plans (i.e. plans that should
indeed be run for this specific patient at this time) in the PICARD
DSS engine’s log; and the completeness, i.e., the portion of theFig. 12. The technical eguideline’s plans that should be applied, which actually existed
in the PICARD engine’s log file. Note that during the development
of a guideline-application engine, feedback from the technical eval-
uation will be used by the engine’s developer and by the knowl-
edge engineers, who might not have represented the guideline in
a sufficiently correct or consistent manner.5.2. The functional evaluation
In addition to the technical evaluation described in Section 5.1,
which used scenarios and patient records generated by the
guideline-scenario simulator, we wanted to test the actual clinical
scenarios that would be used in the clinically oriented evaluation.
We wanted (a) to examine the behavior of the PICARD DSS engine
on these scenarios, and (b) to assess the validity of its recommen-
dations by actual domain experts.
For the functional and the clinically oriented evaluations, we
created with the assistance of several domain experts (who were
not part of the clinically oriented evaluation) six common clinical
scenarios that were judged as nontrivial disease courses that are
important to handle correctly when treating patients using the
PET guideline. The scenarios occur in a series of steps over a signif-
icant stretch of time, lasting from two days to four weeks, and
include a total of 60 decision points. The first two scenarios were
relatively simple ones for the management of mild PET. The other
four scenarios were relatively more complex scenarios that occur
during the management of severe PET.
Table 7 lists the precise type and number of knowledge roles in
each scenario. Each of the six scenarios contained on average 161
knowledge roles.valuation process.
Table 7
Characteristics of the six scenarios used in the functional and clinically oriented evaluation.
Knowledge role type Knowledge role Scenario no. Average
1 2 3 4 5 6
Eligibility and setup conditions Filter 1 (1%) 1 (1%) 1 (1%) 0 (0%) 1 (0%) 0 (0%) 1 (1%)
Setup 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Monitor conditions Suspend, Abort, Complete, or Reactivate 4 (3%) 4 (3%) 9 (5%) 7 (5%) 11 (5%) 7 (4%) 7 (4%)
Plan body – Sub-plans Parallel 17 (12%) 17 (12%) 26 (13%) 19 (13%) 26 (12%) 21 (13%) 21 (13%)
Sequential 0 (0%) 0 (0%) 3 (2%) 5 (3%) 4 (2%) 3 (2%) 3 (2%)
Plan body – Single action Asynchronous 5 (4%) 5 (3%) 7 (4%) 5 (3%) 7 (3%) 5 (3%) 6 (4%)
IfThenElse 0 (0%) 0 (0%) 5 (3%) 5 (3%) 5 (2%) 5 (3%) 3 (2%)
Cyclical 13 (9%) 13 (9%) 21 (11%) 9 (6%) 23 (11%) 9 (6%) 15 (9%)
PatientDataEntry 76 (54%) 76 (53%) 82 (41%) 76 (50%) 86 (40%) 75 (48%) 79 (47%)
Procedure 2 (1%) 2 (1%) 4 (2%) 3 (2%) 4 (2%) 8 (5%) 4 (2%)
Time annotation TimeAnnotation 22 (16%) 22 (15%) 33 (17%) 16 (11%) 36 (17%) 16 (10%) 24 (14%)
Total number of knowledge roles 140 140 191 145 203 149 161
Total number of generated transactions 1626 962 2647 2981 2038 3513 2295
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nario 1) are involved with patient data entry – possibly due to mul-
tiple laboratory tests and physical symptoms such as blood
pressure measurements. Around 15% of the knowledge roles are
time annotations, such as when to start a plan, or what would be
its typical duration.
In order to perform the functional and clinically oriented eval-
uations, we used the GL-based patient-record generation simulator
to generate longitudinal courses for six prototypical patients, one
for each scenario. Each GL-specific patient course included thou-
sand of transactions (each transaction is data entry, such as lab
result). On average, 2295 transactions were generated for each sce-
nario (see at the bottom of Table 7).
The PICARD DSS engine applied the six scenarios to the six sim-
ulated records, and two senior domain experts who were not part
of the clinically oriented evaluation judged the validity of the sys-
tem’s recommendations for the six scenarios (i.e., for the total 60
decisions). Judging involved marking each recommendation as
‘‘valid” or ‘‘invalid”. Similarly, the domain experts judged whether
the explanations generated for each recommendation was valid.
The objective of the functional evaluation was to validate the
PET knowledge base and its application by the PICARD DSS engine,
and thus (assuming it is successful) enable us to move on to the
clinically oriented evaluation.
5.3. The clinically oriented evaluation
To measure the effect of the PICARD DSS framework on the clin-
icians’ decision-making performance, we performed after the suc-
cessful functional evaluation, with the assistance of a group of
clinicians, a rigorous evaluation that used the six longitudinal
records generated for the six clinical scenarios of the eclampsia/
toxemia (PET) GL used in the functional evaluation. The objective
of the evaluation was to test the effects of managing the simulated
patients over time with and without the GL application engine (i.e.,
in an automated DSS mode or in a manual non-DSS mode, with
respect to the decision support that the physicians received. A
complete description of the experimental design of the PET study
and of its results is out of the scope of the current paper, and is
described elsewhere [44]. In this paper we shall briefly summarize
both of these aspects, to demonstrate that realistic GL application
is both feasible and beneficial.
The clinically oriented evaluation was a full-fledged cross-over
simulated clinical evaluation with the help of 36 clinicians, includ-
ing 24 residents and 12 board-certified specialists at an academic
OB/GYN department that handles around 15,000 deliveries annu-
ally, who volunteered to assist us in the evaluation. Each clinicianmanaged three scenarios without using the PICARD DSS engine,
i.e., in a non-DSS mode, and three scenarios using the PICARD
DSS engine, i.e., in a DSS mode. After the experiment, a question-
naire was administered to the practitioners to assess their atti-
tudes regarding the use of the PICARD DSS engine, and their
willingness to use it in the future. Finally, an expert assessed the
correctness of the actions suggested by the physicians, relative to
the ACOG PET GL, and their completeness, i.e., whether all of the
ACOG GLs’ relevant recommendations were followed.
To assess the clinically oriented performance, we defined two
main measures: the correctness, i.e., the percentage of the clini-
cian’s actions that were correct (i.e. actions that should indeed be
performed for this specific patient at this time according to the
guideline); and the completeness, i.e., the percentage of the guide-
line’s recommended actions that were in fact applied, at the appro-
priate time, by the clinician.
6. Results
6.1. The technical evaluation’s results
6.1.1. The knowledge roles generated by the simulated scenarios
We applied 19 guideline-based instantiated scenarios, based on
a corresponding number of legal theoretical scenarios generated by
our guideline-based simulation engine (see Section 5.1): 14 for
severe PET, and 5 for mild PET. For each instantiated scenario, a
complete longitudinal patient record was generated by the simula-
tion module. Table 8 describes the total application cardinality of
the instantiated scenarios, as represented, using the Asbru lan-
guage, in the knowledge base. Each of the instantiated scenarios
was composed on average of more than 120 KRs (ranging from
121 to 136) and was decomposed on average into 17 parallel
sub-GLs, several asynchronous plans and more than 10 cyclical
plans. An average instantiated scenario created thousands of
knowledge role instances, ranging from 374 to 8498, and gener-
ated thousands of simulated transactions, ranging from 1309 to
7102. Note that the numbers depend, of course, on the particular
simulated longitudinal record generated for each instantiated sce-
nario, and on the duration of the application selected for it; but
nevertheless, they provide a reasonable estimate of the instanti-
ated scenario’s total application cardinality, with which the
PICARD engine has had to contend.
We tested the capability of the PICARD DSS engine to handle the
monitoring of all of the Asbru plans monitored conditions by the
internal monitoring unit. The mean number of monitored condi-
tion instances in the severe PET GL was 13,107 ± 24,788.17, rang-
ing from 518 to 97,561; the corresponding number for the mild
Table 9
The average monitored item frequencies in both type of instantiated guideline instances.
Monitored item type Average of the severe PET instantiated
guideline instances (N = 14)
Average ± SD
Average of the mild PET instantiated
guideline instances (N = 5)
Average ± SD
Condition evaluated to true 7 ± 2.7 5 ± 0.54
Cyclical plan re-instantiate 477 ± 252.04 194 ± 67.3
Plan instance finish time 374 ± 198.02 242 ± 84.51
Plan exists in DB 15 ± 6.7 173 ± 171
Notification to client 869 ± 445.72 318 ± 301
Start first repetition 3 ± 0.72 5 ± 4.1
Asynch condition evaluated to true 2 ± 0 1 ± 1
Plan start time 1 ± 0.99 0
Total 1745 ± 895.97 937 ± 323.12
Table 10
Results of the technical evaluation of PICAD DSS.
Scenario (no.) Number of steps in simulation Number of steps in PICARD-DSS log PICARD-DSS correctness PICARD-DSS completeness
1 129 120 1.00 0.930
2 131 120 1.00 0.916
3 116 111 1.00 0.957
4 117 116 1.00 0.991
5 117 111 1.00 0.949
6 119 116 1.00 0.975
7 128 116 1.00 0.906
8 130 121 1.00 0.931
9 121 113 1.00 0.934
10 130 122 1.00 0.938
11 125 117 1.00 0.936
12 118 113 1.00 0.958
13 121 117 1.00 0.967
14 114 113 1.00 0.991
15 121 120 1.00 0.992
16 122 121 1.00 0.992
17 121 120 1.00 0.992
18 121 120 1.00 0.992
19 122 121 1.00 0.992
Total average 116.8 ± 24.95 112.05 ± 23.58 1 ± 0 0.96 ± 0.03
Table 11
The total application cardinality of the six instantiated scenarios used for functional assessment.
Scenario no. Average no. of plan instances
1 2 3 4 5 6
Total number of plan-instances generated at runtime by the Picard DSS 181 205 231 525 323 141 268
Table 8
The total application cardinality of both types of the simulated instantiated scenarios.
Asbru knowledge role type Average of the severe PET instantiated
guideline instances (N = 14)
Average ± SD
Average of the mild PET instantiated
guideline instances (N = 5)
Average ± SD
Number of knowledge roles, other than plan-body instances 130 ± 5.13 121 ± 0.44
Number of monitored items by the internal monitored unit 1745 ± 895.87 937 ± 323.12
Number of instances of knowledge roles created during the application 5417 ± 2835.57 1697 ± 422.35
Number of simulated data transactions 5048 ± 1720.11 1437 ± 517.53
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the severe PET GL, the ‘‘Suspend” monitor condition was the condi-
tion with the highest monitoring frequency (an average of
7870 ± 18,323.82 times, ranging from 0 to 70,940), followed by
the Asynchronous (average of 3560 ± 6329.08 times, ranging from
143 to 24,320) and ‘‘Complete” conditions (average of
1496 ± 805.32 times, ranging from 168 to 2682).
In addition, we tested the capability of the PICARD DSS engine
to handle the monitoring of all of the monitored items by themonitoring unit. Table 9 shows the results of the average number
of monitored items in the scenarios of severe PET andmild PET (see
Section 2.4.3 for the details of monitoring item type). In total, the
monitoring unit of the PICARD DSS engine monitored an average
of 1745 ± 895.97 items for the case of severe PET, and
937 ± 323.12 items in the case of mild PET. For both cases, the
monitored item types ‘‘Notification to client”, ‘‘Cyclical plan
re-instantiate” and ‘‘Plan-instance finish time” had the highest
number.
Table 12
The original requirements and how they were answered by the design, implementation, and evaluation of the PICARD framework.
Req.
number
Requirement description How the PICARD framework answers the requirement Section in which the
details appear
1 Support for a continuous application of the
GLs
Modified knowledge schemas, design and implementation of a GL application unit
and of a complete monitoring unit
2.3, 2.4.4, 2.5
2 Ensuring that the recommendations have
actually been carried out
Modified knowledge schemas with different types of recommendations, and
implement mechanism to ensure recommendation adherence
2.4.1, 2.4.2
3 Supporting a data-driven, asynchronous
application
Enhancing the Asbru procedural schema by a Monitoring plan-body, and developing
a monitoring unit to handle asynchronous calls
2.3, 2.4.3
4 Support of multiple tasks through different
APIs
Design and implementation of different client APIs for multiple tasks 2.2
5 Provision of explanations Design and implementation of an explanation mechanism 2.6
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Table 10 shows the results of this evaluation. Note that the cor-
rectness score was 1 for all scenarios, which means that the
PICARD DSS engine always recommended the correct recommen-
dations. However, the completeness varied between 0.91 and
0.99. When we looked for the reason for this, we found that there
was a problem in the GL modeling: some plans such as ‘‘Patient
follow-up” had been defined as cyclical plans and not as asyn-
chronous ones. Thus, there was inconsistency in the log at the
times of the plans. This assessment allowed us to fix this problem
and run it again with complete results.
6.2. The results of the functional evaluation
Recall that we created, with the help of several domain experts,
six clinical scenarios that were judged as common when managing
patients using the PET GL. We wanted to evaluate the behavior of
the PICARD DSS engine when applying these scenarios, and to
assess the validity of its recommendations by the experts.
Table 11 summarizes the characteristics of the six scenarios,
and the results of applying them using the PICARD DSS engine with
respect to the number of plan instances generated at runtime.
Applying the Picard DSS to the six scenarios generated on aver-
age 268 plan-instances per scenario (see Table 11). Note that this
number is rather low compared to the average number of plan-
instances generated in the technical evaluation. A likely explana-
tion is that unlike the simulated scenarios used in the technical
evaluation, which included multiple branches that might well be
quite unlikely in practice, the scenarios used here were highly real-
istic ones.
All of the scenarios’ workflows were tested by the two senior
domain experts. All of the 60 recommendations generated by the
Picard DSS for the six scenarios were found to be correct. All of
the explanations (generated automatically from the GL knowledge
base, using the text of the relevant knowledge role, and its seman-
tics) were created, and were judged to be valid as well; only several
minor comments were made. No functional bugs were found.
Thus, we were satisfied that no major bugs existed in the GL’s
knowledge base, and that the PICARD DSS engine could correctly
apply the six clinical scenarios.
6.3. The results of the clinically oriented evaluation: The effects of
using or not using a DSS
We summarize here only the key experimental results that are
important for assessing the effectiveness of the Picard realistic GL-
application architecture; a detailed exposition of this evaluation is
provided elsewhere [44].
With respect to completeness, the clinicians applied approxi-
mately only 41% of the GL’s recommended actions in the
non-DSS mode. Completeness increased to a performance ofapproximately 93% of the guideline’s recommended actions, when
using the DSS mode. The mean completeness of the decision-points
(each decision-point being represented by the mean completeness
across all of the clinicians making that decision) for non-DSS mode
was 48.63 ± 29.5%, ranging from 0% to 94.4%. Completeness was
especially low, in the non-DSS mode, for actions of type ‘‘manage-
ment by medications” and of type ‘‘ordering a procedure.” [44]. The
mean completeness in the DSS mode was 93.98 ± 10.09%, ranging
from 44.44% to 100%.
With respect to correctness, approximately 94.5% of the clini-
cians’ decisions in the non-DSS mode were correct. However, these
94.5% correct actions actually consisted of 68% that were correct
but redundant, given the patient’s data (e.g., repeating unnecessar-
ily tests that had been previously performed, or whose results
appear in the original case provided to the clinicians), and 27% that
were indeed necessary in the context of the GL and of the given
scenario. Only 5.5% of the decisions were definite errors. In the
DSS mode, 94% of the clinicians’ decisions were correct, which
included 3% that were correct but redundant, and 91% that were
correct and necessary in the context of the GL and of the given sce-
nario. Only 6% of the DSS-mode decisions were erroneous.
With respect to the subjective questionnaire we administered,
The DSS was assessed by the clinicians as potentially useful.
7. Summary, discussion, and lessons learned
In this study, we have first presented (in Section 1.1) several key
requirements for a realistic GL application architecture. Then, to
fulfil these requirements, we have proposed the PICARD architec-
ture, which includes within it the PICARD DSS engine for GL appli-
cation. The design, implementation, and rigorous evaluation of the
PICARD framework answer all of the requirements. Table 12 sum-
marizes the requirements and how they were answered by the
design, implementation and/or evaluation of the PICARD
framework.
We have also presented two specific instances of applications of
the PICARD architecture (see Section 3), and have demonstrated its
functional feasibility and validity through a technical evaluation
using a set of simulated instantiated guideline scenarios (see Sec-
tions 6.1 and 6.2). In addition, we summarized the design and
results of a clinically oriented cross-over evaluation in the pre-
eclampsia/toxemia domain, assisted by 36 clinicians, in which we
had shown that using the PICARD DSS engine to support the appli-
cation of six different simulated longitudinal clinical scenarios
increased the clinicians’ compliance with the guideline’s recom-
mendations (see Section 6.3).
Several insights emerged from the current study.
(1) We learned that the GL application engine should support
different APIs for different types of application tasks. For this
purpose, we developed a designated set of APIs for each task.
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API with a much smaller set of messages than was developed
for the task of GL debugging, but that was still sufficiently
expressive with respect to its semantics.
(2) The application of the PICARD architecture is quite generic
and modular. Using the system with a new EMR, possibly
to apply a new GL, mostly involves a mapping of the current
or new knowledge base’s terms and units to those of the
local EMR.
(3) In addition, the PICARD architecture can help guideline
developers in developing clinical guidelines, by running a
simulation of the GL on several patient test cases, which
might highlight interesting behaviors that would suggest
specific issues and questions regarding various aspects of
the GL.
(4) During this study, we realized the need, when supporting a
realistic application of a GL, for a simulation engine that
can support a simulation of a longitudinal application of
the GL over significant stretches of time. The simulation
engine should be able to generate all of the GL’s legal scenar-
ios, given the GL’s formal description, and also the corre-
sponding set of simulated longitudinal patient data, to test
the GL application engine. Indeed, as a result, such a GL-
based simulation engine had been built and evaluated rigor-
ously in our laboratory. Such a simulation capability is
mandatory for a realistic automated application of clinical
GLs, as it is the only way to test the GL-application engine’s
capability to apply a complex GL over time.
(5) Our technical evaluation, assisted by the GL-based simula-
tion engine, resulted in a technical correctness of 100%,
and a technical completeness of 96%, for the particular sim-
ulated instantiated GL scenarios we used, thus highlighting
potential problems in the knowledge base or in the applica-
tion engine that we could focus on.
(6) Although the system architecture was built and designed to
support the application of a GL to large numbers of patients,
one potential technical limitation of the current study is that
we tested it in a real clinical pilot (the EU MobiGuide pro-
ject) on only several dozens of patients. We also tested the
Picard engine offline with several hundreds of simulated
patients, without observing any particular problem. How-
ever, our future research will examine the implications of
applying the Picard architecture to many thousands of
patients, which might result in an even more robust and
scalable design.
(7) Finally, we performed a clinically oriented evaluation, in
which we evaluated quantitatively the added value of the
application engine to a human care provider, by performing
a cross-over design including two groups of clinical users,
each decision (out of 60 clinical decisions per user) being
performed either with or without automated support from
the Picard DSS. Both groups applied the same six specific
sub-scenarios from the pre-eclampsia/toxemia GL, which
were simulated by the GL-based simulation engine, and for
which the corresponding realistic longitudinal patient
records over significant stretches of time (up to four weeks
each) were generated. The correctness in the DSS arm was
94%, versus 94.5% in the non-DSS arm; the completeness in
the DSS arm was 93%, versus 41% in the non-DSS arm. Fur-
thermore, the results demonstrated that the GL-based DSS
played the role of a ‘‘big equalizer”: it created independence
of the quality of the decision regardless of any particular
physician, any particular clinical scenario, and any particular
decision type.8. Conclusions
The PICARD architecture addresses the realistic-application
requirements that we have defined, and in particular, the require-
ments for GL-based care over a continuous, longitudinal, signifi-
cant time frame, for data-driven and user-driven GL application,
and for support of several different types of tasks and users. The
technical, functional, and clinical-simulation evaluation results
suggest that the use of the PICARD DSS engine results in a high
quality of clinical decision making, assessed relative to a
guideline-based norm. Given our rather generic methodology, we
conclude that the PICARD architecture might be potentially bene-
ficial as a general framework to provide automated support for
GL-based chronic patient management.Conflict of interest
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